MPX Bioceutical Corporation (CSE.MPX) (OTC.MPXEF) secured a $40 million convertible loan on Tuesday to fund future expansion. The convertible loan will also be invested in acquisitions and new production licenses in both the United States and Canada.

Tilray Canada has launched its newest product, Tilray 2:100, a formulation of therapeutic cannabis oil containing a high concentration of cannabidiol (CBD), which may help treat Canadian patients with conditions like Dravet syndrome.

India Globalisation Capital has been trialling a therapy that can restore memory in mice, promising potential for the treatment of Alzheimer’s.

Based on $143 million raise, MedMen appears to be the most valuable public U.S. marijuana company to date.

Shares of upscale U.S. marijuana retailer MM Enterprises USA LLC are expected to begin trading on the Canadian Securities Exchange Tuesday, following the reverse takeover of a Canadian shell company and a $143-million raise that gives the company an implied value of more than $2 billion.

MedMen, which will trade as MMEN after acquiring oil and gas shell Ladera Ventures Corp., is by far the largest company listed on the CSE, and is expected to be the most valuable public U.S. marijuana company to date.

In 2012, Washington State voted to legalize marijuana. By 2014, the world’s first system for legally growing, processing and retailing cannabis was operating.

As Canada prepares to go live with pot sales in a few months, what can we learn from four years of practical, hands-on experience in the western United States?

The first take-away is that all the fretting about the impact on children and teens is largely unwarranted.

Before legalization, 17 per cent of Grade 10 students in Washington State said they had smoked pot in the previous month. Four years of legal doobies later, 17 per cent of Grade 10 students say they have smoked pot in the previous month.

Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues to expand its extensive intellectual property portfolio through the recent filing of 2 additional Canadian patent applications. Canntab's portfolio now includes 13 patent applications in Canada, the United States and internationally. These filings build on Canntab's growing intellectual property portfolio, which already included patent applications and trademark applications in the United States and Canada.

Sustainability is a hot-button topic that’s become increasingly important as commercial cannabis farms scale up with expanding legalization. To be “sustainable” means you’re able to maintain a level of output continuously. With farming, this means providing the correct inputs for a healthy and thriving ecosystem as you take outputs from the land. Amending soil, introducing crop diversity, and sourcing water efficiently are all part of sustainable agriculture.

For an emerging group of cultivators, sustainable farming is not answering to the needs of our environment. That’s where regenerative agriculture comes in.

Simply put, Big Pharma has been a long time opponent of legalizing medical marijuana as it threatens to ruin its business and drop the market cap for pharmaceutical drug companies.

Even though medical cannabis has been legalized in more than half of the US states, all of Canada and in Mexico, prices of drugs that could be replaced by cannabis are still on the rise.

Worse yet, prices of drugs that are made from the cannabis flower are being artificially inflated in places where medical marijuana is legal, but most recently in Germany of all places.

This is due to the fact that the Big Pharma has so far only competed with the black market when it comes to marijuana, but now all of that is starting to change.

Why Go Public in Canada?

Medical marijuana has been making breakthroughs for years with technology continuing to advance at a rapid pace.

With laws changing all of the time and more research being done on the medical benefits of cannabinoids found in marijuana, we are witnessing some exciting things happening in the medical industry. We’ve compiled a list of just ten of the more recent major medical marijuana breakthroughs:

1. Brain Cancer